An interventional study of Nutrilite Glucose health herbal drink and Placebo drink in PreDiabetes, sponsored by Amway (China) R&D Center. Completed at 1 site in China. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-08.
Sponsored by Amway (China) R&D Center · Not applicable, Interventional, and Treatment
The goal of this two arms, randomized, double-blind controlled trial is to study whether Nutrilite herbal drink could ameliorate blood glucose level in prediabetes population.
100 eligible Participants aged 18-65 years will be enrolled in one center. Participants will be randomly assigned to two study groups, with 50 subjects in each group.Study subjects will be administrated with either the Nutrilite product or a placebo drink for two months (8 weeks). And up to three study visits will be made by the subject over a 2-month period intervention.
Researchers will compare two groups to see if consumption of Nutrilite herbal drink could significantly ameliorate blood glucose level at the end of the study.
999 studies on the registry are indexed under Prediabetic State; 238 are open to participants now.
This study's enrollment of 117 is above the median of 65 across 844 interventional studies indexed under Prediabetic State.
Browse Prediabetic State studies →Amway (China) R&D Center is the lead sponsor of 7 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Dietary Supplement: Nutrilite Glucose health herbal drink
Dietary Supplement: Placebo drink
1 sachet per time, 3 times a day after meal
1 sachet per time, 3 times a day after meal
Changes in blood glucose level（fasten plasma glucose）
fasten plasma glucose
Time frame: baseline day 0, day 56
Changes in blood glucose level (2-hour postprandial blood glucose levels)
2-hour postprandial blood glucose levels
Time frame: baseline day 0, day 56
changes of glycated hemoglobin
HbA1c level
Time frame: baseline day 0, day 56
Changes in islet function (insulin level)
insulin level
Time frame: baseline day 0, day 56
changes in islet function (C-peptide level)
C-peptide level
Time frame: baseline day 0, day 56
Changes in blood lipids profile (TC)
Total cholesterol
Time frame: baseline day 0, day 56
Changes in blood lipids profile (TG)
total triglycerides
Time frame: baseline day 0, day 56
Symptom observation
A clinical symptom scoring scale for abnormal glucose metabolism was formulated with reference to Internal Medicine of Traditional Chinese Medicine. Symptoms were scored by mild, moderate and severe grades. Total scores were recorded before and after the trial food administration to calculate the clinical symptom improvement rate. The main observed clinical symptoms include excessive thirst with frequent drinking, polyphagia with easy hunger, frequent micturition and other related manifestations.
Time frame: baseline day 0, day 56
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Amway (China) R&D Center